Increased cardiac yroponin T levels are related to inflammatory markers and various indices of renal function in chronic renal disease patients

Renal Failure

Volumn 34, Issue 4, 2012, Pages 454-459

  Sezer, Siren ^a   Karakan, Sebnem ^a   Ozdemir, Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Cardiac troponin T; Cardiovascular risk; Chronic kidney disease

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; PHOSPHORUS; TRIACYLGLYCEROL; TROPONIN T; UREA; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UREA BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEART MUSCLE; INCIDENCE; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR; TURKEY (REPUBLIC);

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; RISK FACTORS; TROPONIN T; TURKEY;

EID: 84859612726     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.656562     Document Type: Article

References (33)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:16-23.
2. Manjunath G, Tighiouart H, Coresh J, Macleod B. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63:1121-1129. (Pubitemid 36315592)
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-2169. (Pubitemid 37337595)
4. Urso S, Garozzo M, Milone F, Battaglia G. Cardiovascular risk markers in hemodialysis patients. Int J Artif Organs. 2004;27:1083-1090.
5. Abbas NA, John RI, Webb MC, Kempson ME. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem. 2005;51:2059-2066. (Pubitemid 41532621)
6. Ooi DS, House AA. Cardiac troponin T in hemodialyzed patients. Clin Chem. 1995;44:1410-1416. (Pubitemid 28309099)
7. Dierkes J, Domrose U, Westphal S, Ambrosch A. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation. 2000;102:1964-1969.
8. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in endstage renal disease. Circulation. 2002;106:2941-2945. (Pubitemid 35424746)
9. Ishii J, Nomura M, Okuma T, Minagawa T. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clin Chim Acta. 2001;312:69-79. (Pubitemid 32913582)
10. Diris JH, Hackeng CM, Kooman JP, Pinto YM. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation. 2004;109:23-25. (Pubitemid 38056015)
11. Sharma R, Gaze DC, Pellerin D. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart. 2006;92:804-809. (Pubitemid 43799216)
12. Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: Incidence and clinical significance. Chest. 2004;125:1877-1884. (Pubitemid 38648423)
13. Lamb EJ, Wbb MC, Abbas NA. The significance of serum troponin T in patients with kidney disease: A review of the literature. Ann Clin Biochem. 2004;41:1-9. (Pubitemid 38175090)
14. National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: Evaluation classification and stratification. Am J Kidney Dis. 2002;39:S1-S266.
15. Platt JF, Ellis JH, Rubin JM. Intrarenal arterial Doppler sonography in patients with nonobstructive renal disease: Correlation of resistive index with biopsy findings. AJR Am J Roentgenol. 1990;154:1223-1227. (Pubitemid 20179469)
16. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613-618. (Pubitemid 8066109)
17. Koren MJ, Devereux RB, Casale PN, Savage DD. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
18. Collinson PO, Hadcocks L, Foo Y, Rosalki SB. Cardiac troponins in patients with renal dysfunction. Ann Clin Biochem. 1998;35:380-386. (Pubitemid 28230736)
19. Wood GN, Keevil B, Gupta J, Foley R. Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: A 2 year prospective study. Nephrol Dial Transplant. 2003;18:1610-1615. (Pubitemid 36939636)
20. Roppolo LP, Fitzgerald R, Dillow J, Ziegler T. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a veteran's hospital: A pilot study. J Am Coll Cardiol. 1999;34:448-454.
21. Goicoechea M, Garca de Vinuesa S, Gomez-Campdera F, Gutierrez MJ. Clinical significance of cardiac troponin T levels in chronic kidney disease patients: Predictive value for cardiovascular risk. Am J Kidney Dis. 2004;43: 846-853. (Pubitemid 38529622)
22. Zoccali C, Benedetto FA, Mallamaci F. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens. 2000;18:1207-1213.
23. Stenvinkel P. Inflammation in end-stage renal disease: The hidden enemy. Nephrology (Carlton). 2006;11:36-41.
24. Lowbeer C, Stenvinkel P, Pecoits-Filho R. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med. 2003;253: 153-160. (Pubitemid 36197535)
25. Baldus S, Koster R, Chumley P, Heitzer T. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med. 2005;39:1184-1190. (Pubitemid 41407712)
26. Fredericks S, Chang R, Gregson H, Bewick M. Circulating cardiac troponin-T in patients before and after renal transplantation. Clin Chim Acta. 2001;310:199-203. (Pubitemid 32728350)
27. Freda BJ, Tang WH, Van Lente F, Peacock WF. Cardiac troponins in renal insufficiency: Review and clinical implications. J Am Coll Cardiol. 2002;40:2065-2071. (Pubitemid 36005889)
28. Vickery S, Price CP, John RI, Abbas NA. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: Relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis. 2005;46:610-620. (Pubitemid 41383938)
29. Madsen LH, Ladefoged S, Corell P, Schou M. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int. 2007;71:548-554. (Pubitemid 46398682)
30. Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol. 1998;9:1018-4022.
31. Amann K, Ritz E. Cardiac disease in chronic uremia: Pathophysiology. Adv Ren Replace Ther. 1997;4:212-224. (Pubitemid 27304996)
32. Kaye D, Pimental D, Prasad S, Maki T. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J Clin Invest. 1996;97:281-291.
33. deFilippi CR, Thorn EM, Aggarwal M, Joy A. Frequency and cause of cardiac troponin T elevation in chronic hemodialysis patients from study of cardiovascular magnetic resonance. Am J Cardiol. 2007;100:885-889. (Pubitemid 47268284)